Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James D Marks

Showing results (31-40 of 127) with videos related to

Pageof 13
Sort By:
Talanta|November 12, 2013
RNA aptasensor for rapid detection of natively folded type A botulinum neurotoxinPavithra Janardhanan, Charlene M Mello, Bal Ram Singh, et al.
BMC Immunology|October 4, 2006
A novel assay for monitoring internalization of nanocarrier coupled antibodiesUlrik B Nielsen, Dmitri B Kirpotin, Edward M Pickering, et al.
Analytical Biochemistry|March 13, 2012
A functional dual-coated (FDC) microtiter plate method to replace the botulinum toxin LD50 testYvonne Y B Liu, Peter Rigsby, Dorothea Sesardic, et al.
The Journal of Biological Chemistry|November 23, 2007
Molecular architecture of botulinum neurotoxin E revealed by single particle electron microscopyAudrey Fischer, Consuelo Garcia-Rodriguez, Isin Geren, et al.
Molecular Imaging and Biology|June 2, 2011
An engineered cysteine-modified diabody for imaging activated leukocyte cell adhesion molecule (ALCAM)-positive tumorsKatelyn E McCabe, Bin Liu, James D Marks, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
Regulation of antibody-dependent cellular cytotoxicity by IgG intrinsic and apparent affinity for target antigenYong Tang, Jianlong Lou, R Katherine Alpaugh, et al.
Cancer Research|November 26, 2009
Construction and characterization of novel, recombinant immunotoxins targeting the Her2/neu oncogene product: in vitro and in vivo studiesYu Cao, James D Marks, John W Marks, et al.
The Biochemical Journal|April 30, 2013
Identification of the SV2 protein receptor-binding site of botulinum neurotoxin type EStefan Mahrhold, Jasmin Strotmeier, Consuelo Garcia-Rodriguez, et al.
European Journal of Immunology|October 2, 2002
The cleavage site of C5 from man and animals as a common target for neutralizing human monoclonal antibodies: in vitro and in vivo studiesRoberto Marzari, Daniele Sblattero, Paolo Macor, et al.
FEBS Letters|March 4, 2014
Identification of the synaptic vesicle glycoprotein 2 receptor binding site in botulinum neurotoxin AJasmin Strotmeier, Stefan Mahrhold, Nadja Krez, et al.
Pageof 13

Showing results (31-40 of 127) with videos related to

Sort By:
Pageof 13
Talanta|November 12, 2013
RNA aptasensor for rapid detection of natively folded type A botulinum neurotoxinPavithra Janardhanan, Charlene M Mello, Bal Ram Singh, et al.
BMC Immunology|October 4, 2006
A novel assay for monitoring internalization of nanocarrier coupled antibodiesUlrik B Nielsen, Dmitri B Kirpotin, Edward M Pickering, et al.
Analytical Biochemistry|March 13, 2012
A functional dual-coated (FDC) microtiter plate method to replace the botulinum toxin LD50 testYvonne Y B Liu, Peter Rigsby, Dorothea Sesardic, et al.
The Journal of Biological Chemistry|November 23, 2007
Molecular architecture of botulinum neurotoxin E revealed by single particle electron microscopyAudrey Fischer, Consuelo Garcia-Rodriguez, Isin Geren, et al.
Molecular Imaging and Biology|June 2, 2011
An engineered cysteine-modified diabody for imaging activated leukocyte cell adhesion molecule (ALCAM)-positive tumorsKatelyn E McCabe, Bin Liu, James D Marks, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
Regulation of antibody-dependent cellular cytotoxicity by IgG intrinsic and apparent affinity for target antigenYong Tang, Jianlong Lou, R Katherine Alpaugh, et al.
Cancer Research|November 26, 2009
Construction and characterization of novel, recombinant immunotoxins targeting the Her2/neu oncogene product: in vitro and in vivo studiesYu Cao, James D Marks, John W Marks, et al.
The Biochemical Journal|April 30, 2013
Identification of the SV2 protein receptor-binding site of botulinum neurotoxin type EStefan Mahrhold, Jasmin Strotmeier, Consuelo Garcia-Rodriguez, et al.
European Journal of Immunology|October 2, 2002
The cleavage site of C5 from man and animals as a common target for neutralizing human monoclonal antibodies: in vitro and in vivo studiesRoberto Marzari, Daniele Sblattero, Paolo Macor, et al.
FEBS Letters|March 4, 2014
Identification of the synaptic vesicle glycoprotein 2 receptor binding site in botulinum neurotoxin AJasmin Strotmeier, Stefan Mahrhold, Nadja Krez, et al.
Pageof 13